Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Natasha van Eijkelenburg

Pediatric oncologist, PhD student
Natasha van Eijkelenburg
Natasha van Eijkelenburg
--
  • Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML

    • jan. 2023
    • Alba, Rubio-San-Simón, et al
    • Paediatric drugs
  • Fatigue trajectories during pediatric ALL therapy are associated with fatigue after treatment

    • dec. 2022
    • Elin, Irestorm, et al
    • Supportive Care in Cancer
  • Implementation of paediatric precision oncology into clinical practice

    • nov. 2022
    • Karin P.S., Langenberg, et al
    • European Journal of Cancer
  • Parental Sleep, Distress, and Quality of Life in Childhood Acute Lymphoblastic Leukemia

    • jun. 2022
    • Niki, Rensen, et al
    • Cancers
  • Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies

    • nov. 2021
    • Francisco, Bautista, et al
    • Journal of Clinical Oncology
View all publications